Ghana vs Marshall Islands: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Marshall Islands
100.0%
in 2024
Ghana rank
1st
Marshall Islands rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Marshall Islands
How they compare
Ghana currently reports 100.0% against 100.0% in Marshall Islands, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2005 it was Marshall Islands ahead.
Ghana ranks 1st and Marshall Islands ranks 1st of 180 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and Marshall Islands in 2.
Head to head by decade
| Decade | Ghana | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.4% | 60.0% | 59.6% | Marshall Islands |
| 2010s | 68.2% | 40.9% | 27.3% | Ghana |
| 2020s | 98.6% | 100.0% | 1.4% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Marshall Islands?
- Ghana, at 100.0% against 100.0% in Marshall Islands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Marshall Islands?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Marshall Islands?
- 16 years are reported by both, from 2005 to 2024.
- How do Ghana and Marshall Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Marshall Islands ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.